This study was performed to compare the antagonistic effects of intravenous(0.125mg / kg) and subcutaneous(0.25mg /kg) administration of yohimbine on xylazine-induced immobilized(4.5mg/ kg) dog and to investigate the effectiveness of yohimbine compound(0.25mg / kg) in clinical practice. Mean arousal time(MAT), mean walk time(MWT), and time to return to normal electroencephalograms were remarkably decreased in all yohimbine-treated groups compared with the control. In electroencephalograms(A-B$sub$I/ lead), there were no significant alteration, except RR interval. RR interval was decreased in all yohimbine-treated groups compared with the control. Second-degree heart blocks(41.7%) shown after xylazine administration disappeared within 2 min after yohimbine administration. The frequency of electroencephalograms(RO-RF trace) was recovered faster to normal in yohimbine-treated groups than that of the control. In histopathological changes of ICR mice given yohimbine compound subcutaneously, edema with inflammatory cells of hypodermis was slightly shown on the 1st day, but this findings were not observed on the 5th day. It was considered that no difference in the antagonistic effects of intravenous and subcutaneous administration of yohimbine on xylazine- induced immobilized dog were observed and yohimbine compound was usable in clinical practice for antagonistic agent to the xylazine.